スタッフ紹介
植田 圭二郎 業績集
原著論文
Matsumoto K, Fujimori N, Ichihara K, Takeno A, Murakami M, Ohno A, Kakehashi S, Teramatsu K, Ueda K, Nakata K, Sugahara O, Yamamoto T, Matsumoto A, Nakayama KI, Oda Y, Nakamura M, Ogawa Y.
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
J Gastroenterol. 2024 Apr 29. doi: 10.1007/s00535-024-02103-0. Online ahead of print.
Murakami M, Fujimori N, Takamatsu Y, Ito T, Matsumoto K, Kakehashi S, Ohno A, Teramatsu K, Ueda K, Ishigami K and Ogawa Y.
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Jpn J Clin Oncol. 2024 Feb 29:hyae026. Online ahead of print.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
J Gastroenterol. 2023 Jun;58(6):586-597. doi: 10.1007/s00535-023-01987-8. Epub 2023 Apr 26.
Miyagahara T, Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramastu K, Takaoka T, Suehiro Y, Shimokawa Y, Omori K, Niina Y, Tachibana Y, Akashi T, Oono T, Ogawa Y.
Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Asia Pac J Clin Oncol. 2022 Dec 7. doi: 10.1111/ajco.13903. Online ahead of print.
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, Shimokawa Y, Niina Y, Oono T, Hisano T, Furukawa M, Ogawa Y.
Treatment effect and safety of nanoliposomal irinotecan with fluorouracil and folinic acid after gemcitabine-based therapy in patients with advanced pancreatic cancer: A multicenter, prospective observational study.
J Clin Med. 2022 Aug 30;11(17):5084. doi: 10.3390/jcm11175084.
Murakami M, Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ogawa Y.
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience.
Endocr J. 2022 May 27. doi: 10.1507/endocrj.EJ22-0111. Online ahead of print.
Watanabe Y, Ueda K, Nakamura S, Endo S, Kozono S, Nishihara K, Nakano T.
Endoscopic Transpapillary pancreatic duct stento placement for symptomatic peripancreatic fluid collectioncaused by clinically relevant postoperative pancreatic fistula after distal pancreatectomy.
Surg Laparosc Endosc Percutan Tech. 2019 Aug;29(4):261-266.
Watanabe Y, Endo S, Nishihara K, Ueda K, Mine M, Tamiya S, Nakano T, Tanaka M.
The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Surg Today. 2018 Nov;4/(11):1011-1019. doi: 10.1007/s00595-018-1691-2. Epub 2018 Jun 30.
Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y, Fujimori N, Kawabe K, Ogawa Y.
Using CRISPR/Cas9 to knock out amylase in acinar cells decreases pancreatitis-induced autophagy.-
Biomed Res Int. 87:19397, 2018.
Ueda K, Ito T, Kawabe K, Lee L, Fujiyama T, Tachibana Y, Miki M, Yasunaga K, Takaoka T, Nishie A, Asayama Y, Jensen RT, Ogawa Y.
Should the selective arterial secretagogue injection test for insulinoma localization be evaluated at 60 or 120 seconds?
Intern Med. 2017 Nov 15;56(22):2985-2991. doi: 10.2169/internalmedicine.9107-17. Epub 2017 Sep 25.
Fujiyama T, Ito T, Ueda K, Tachibana Y, Yasunaga K, Miki M, Takaoka T, Lee L, Kawabe K, Ogawa Y.
Serum levels of Wisteria floribunda agglutinin-positive Mac-2 binding protein reflect the severity of chronic pancreatitis.
J Dig Dis. 2017 May;18(5):302-308. doi: 10.1111/1751-2980.12475.
Lee L, Ito T, Igarashi H, Ueda K, Fujiyama T, Kawabe K, Ogawa Y.
Imoact of everolimus on japanese patients with advanced pancreatic neuroendocrine neoplasms.
J Hepatobiliary Pancreat Sci. 2017 Feb;24(2):95-102. doi: 10. 1002/jhbp.418
Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igawashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.
Diagnostic performance of 48-Hour fasting test and insulin surrogates in patients with suspected insulinoma.
Pancreas. 2017 Apr;46(4):476-481. doi: 10. 1097/MPA.0000000000000772.
Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T.
Evidence-based clinical practice guidelines for chronic pancreatitis 2015.
J Gastroenterol. 2016 Feb;51(2):85-92. doi: 10.1007/s00535-015-1149-x. Epub 2016 Jan 4.
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
J Gastroenterol. 2024 Apr 29. doi: 10.1007/s00535-024-02103-0. Online ahead of print.
Murakami M, Fujimori N, Takamatsu Y, Ito T, Matsumoto K, Kakehashi S, Ohno A, Teramatsu K, Ueda K, Ishigami K and Ogawa Y.
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Jpn J Clin Oncol. 2024 Feb 29:hyae026. Online ahead of print.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
J Gastroenterol. 2023 Jun;58(6):586-597. doi: 10.1007/s00535-023-01987-8. Epub 2023 Apr 26.
Miyagahara T, Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramastu K, Takaoka T, Suehiro Y, Shimokawa Y, Omori K, Niina Y, Tachibana Y, Akashi T, Oono T, Ogawa Y.
Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Asia Pac J Clin Oncol. 2022 Dec 7. doi: 10.1111/ajco.13903. Online ahead of print.
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, Shimokawa Y, Niina Y, Oono T, Hisano T, Furukawa M, Ogawa Y.
Treatment effect and safety of nanoliposomal irinotecan with fluorouracil and folinic acid after gemcitabine-based therapy in patients with advanced pancreatic cancer: A multicenter, prospective observational study.
J Clin Med. 2022 Aug 30;11(17):5084. doi: 10.3390/jcm11175084.
Murakami M, Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ogawa Y.
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience.
Endocr J. 2022 May 27. doi: 10.1507/endocrj.EJ22-0111. Online ahead of print.
Watanabe Y, Ueda K, Nakamura S, Endo S, Kozono S, Nishihara K, Nakano T.
Endoscopic Transpapillary pancreatic duct stento placement for symptomatic peripancreatic fluid collectioncaused by clinically relevant postoperative pancreatic fistula after distal pancreatectomy.
Surg Laparosc Endosc Percutan Tech. 2019 Aug;29(4):261-266.
Watanabe Y, Endo S, Nishihara K, Ueda K, Mine M, Tamiya S, Nakano T, Tanaka M.
The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Surg Today. 2018 Nov;4/(11):1011-1019. doi: 10.1007/s00595-018-1691-2. Epub 2018 Jun 30.
Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y, Fujimori N, Kawabe K, Ogawa Y.
Using CRISPR/Cas9 to knock out amylase in acinar cells decreases pancreatitis-induced autophagy.-
Biomed Res Int. 87:19397, 2018.
Ueda K, Ito T, Kawabe K, Lee L, Fujiyama T, Tachibana Y, Miki M, Yasunaga K, Takaoka T, Nishie A, Asayama Y, Jensen RT, Ogawa Y.
Should the selective arterial secretagogue injection test for insulinoma localization be evaluated at 60 or 120 seconds?
Intern Med. 2017 Nov 15;56(22):2985-2991. doi: 10.2169/internalmedicine.9107-17. Epub 2017 Sep 25.
Fujiyama T, Ito T, Ueda K, Tachibana Y, Yasunaga K, Miki M, Takaoka T, Lee L, Kawabe K, Ogawa Y.
Serum levels of Wisteria floribunda agglutinin-positive Mac-2 binding protein reflect the severity of chronic pancreatitis.
J Dig Dis. 2017 May;18(5):302-308. doi: 10.1111/1751-2980.12475.
Lee L, Ito T, Igarashi H, Ueda K, Fujiyama T, Kawabe K, Ogawa Y.
Imoact of everolimus on japanese patients with advanced pancreatic neuroendocrine neoplasms.
J Hepatobiliary Pancreat Sci. 2017 Feb;24(2):95-102. doi: 10. 1002/jhbp.418
Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igawashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.
Diagnostic performance of 48-Hour fasting test and insulin surrogates in patients with suspected insulinoma.
Pancreas. 2017 Apr;46(4):476-481. doi: 10. 1097/MPA.0000000000000772.
Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T.
Evidence-based clinical practice guidelines for chronic pancreatitis 2015.
J Gastroenterol. 2016 Feb;51(2):85-92. doi: 10.1007/s00535-015-1149-x. Epub 2016 Jan 4.
著書・総説
伊藤 鉄英、高松 悠、植田 圭二郎
特集 膵NENの診断・治療 膵神経内分泌腫瘍（NEN）診療の現状および今後の展望
膵臓 38(6):361-366, 2023
植田 圭二郎、伊藤 鉄英、河村 康平、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、藤森 尚、小川 佳宏
特集 胆道癌と膵癌のリスクファクター 飲酒と発がん
胆と膵 44(9) 815-819, 2023.9
植田 圭二郎、藤森 尚
膵癌患者における糖尿病
胆膵の病態生理 39(1) 37, 2023.6
伊藤 鉄英、高松 悠、渡邉 洋子、植田 圭二郎、永田 宙生、平松 真祐、白石 素公、矢永 勝彦、恒吉 正澄
膵神経内分泌腫瘍と代謝異常
胆と膵 44(5) 453-458, 2023.5
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
ランレオチドによる膵NETに対する抗腫瘍治療
胆と膵 44(1),2023.1
藤森 尚、大野 彰久、植田 圭二郎、蓑田 洋介、小川 佳宏
治療的EUS Peripancreatic/pancreatic fluid collection(PFD)ドレナージ ステントが迷入してしまった
消化器内視鏡 34(12) 1976-1980, 2022.12
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、竹野 歩、植田 圭二郎、伊藤 鉄英、小川 佳宏
膵神経内分泌腫瘍のリキッドバイオプシー．
肝胆膵 84(6),2022
植田 圭二郎、下川 雄三、秋穂 裕唯、藤森 尚、大野 隆真、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】膵炎の診断方法 膵炎における膵内分泌検査(解説/特集)
胆と膵 (0388-9408)40巻臨増特大 Page1133-1137(2019.11)
特集 膵NENの診断・治療 膵神経内分泌腫瘍（NEN）診療の現状および今後の展望
膵臓 38(6):361-366, 2023
植田 圭二郎、伊藤 鉄英、河村 康平、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、藤森 尚、小川 佳宏
特集 胆道癌と膵癌のリスクファクター 飲酒と発がん
胆と膵 44(9) 815-819, 2023.9
植田 圭二郎、藤森 尚
膵癌患者における糖尿病
胆膵の病態生理 39(1) 37, 2023.6
伊藤 鉄英、高松 悠、渡邉 洋子、植田 圭二郎、永田 宙生、平松 真祐、白石 素公、矢永 勝彦、恒吉 正澄
膵神経内分泌腫瘍と代謝異常
胆と膵 44(5) 453-458, 2023.5
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
ランレオチドによる膵NETに対する抗腫瘍治療
胆と膵 44(1),2023.1
藤森 尚、大野 彰久、植田 圭二郎、蓑田 洋介、小川 佳宏
治療的EUS Peripancreatic/pancreatic fluid collection(PFD)ドレナージ ステントが迷入してしまった
消化器内視鏡 34(12) 1976-1980, 2022.12
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、竹野 歩、植田 圭二郎、伊藤 鉄英、小川 佳宏
膵神経内分泌腫瘍のリキッドバイオプシー．
肝胆膵 84(6),2022
植田 圭二郎、下川 雄三、秋穂 裕唯、藤森 尚、大野 隆真、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】膵炎の診断方法 膵炎における膵内分泌検査(解説/特集)
胆と膵 (0388-9408)40巻臨増特大 Page1133-1137(2019.11)
- スタッフ紹介
- スタッフ紹介
